Humana reaffirms FY2026 EPS guidance: at least $6.52 GAAP, $9.00 adjusted

HUMANA INC

Reaffirms FY2026 diluted EPS guidance of at least $6.52 GAAP and at least $9.00 adjusted EPS, consistent with July 29, 2026 press release.
Will not comment on 2027 Medicare Advantage Star Ratings (Bonus Year 2028) until CMS releases final data in October.
Adjusted EPS excludes $0.30 amortization, $1.47 put/call adjustments, $1.27 value creation, $0.17 impairments, and $(0.73) tax impact.
Company expects no change to adjusted EPS guidance; GAAP EPS may change due to ongoing value creation initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.